麦芽糖糊精

麦芽糖糊精用途

麦芽糊精,葡萄糖当量16.5-19.5可用作赋形剂。药用辅料,或称药用辅料,是指除药物成分外,在制药过程中使用的其他化学物质。药用辅料一般是指药物制剂中的非活性成分,可以提高药物制剂的稳定性、溶解性和加工性。药用赋形剂还影响共同给药药物的吸收、分布、代谢和消除(ADME)过程[1]。

点击显示

麦芽糖糊精名称

[ CAS 号 ]:
9050-36-6

[ 中文名 ]:
麦芽糖糊精

[ 英文名 ]:
Maltodextrin

[中文别名 ]:

麦芽糊精

[英文别名 ]:

EINECS 232-940-4
MFCD00146679
Maltodextrin

麦芽糖糊精生物活性

[ 描述 ]:

[ 相关类别 ]:

研究领域 >> 其他

信号通路 >> 其他 >> 其他

[ 靶点 ]

Human Endogenous Metabolite

[参考文献]

[1]. Elder DP, et al. Pharmaceutical excipients - quality, regulatory and biopharmaceutical considerations. Eur J Pharm Sci. 2016 May 25;87:88-99.

麦芽糖糊精物理化学性质

[ 密度 ]:
1.6±0.1 g/cm3

[ 沸点 ]:
527.1±50.0 °C at 760 mmHg

[ 熔点 ]:
240ºC (dec.)

[ 分子式 ]:
(C₆H₁₀O₅)n·xH₂O

[ 分子量 ]:
180.156

[ 闪点 ]:
286.7±26.6 °C

[ 精确质量 ]:
180.063385

[ PSA ]:
118.22000

[ LogP ]:
-3.17

[ 外观性状 ]:
黄色粉末

[ 蒸汽压 ]:
0.0±3.1 mmHg at 25°C

[ 折射率 ]:
1.573

[ 储存条件 ]:
room temp

[ 水溶解性 ]:
H2O: 0.1 g/mL hot, complete, yellow to very deep yellow

麦芽糖糊精MSDS

详细MSDS(安全技术说明书)

麦芽糖糊精安全信息

[ 个人防护装备 ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ 安全声明 (欧洲) ]:
S24/25

[ 危险品运输编码 ]:
NONH for all modes of transport

[ WGK德国 ]:
3

[ RTECS号 ]:
HH9450000

[ 海关编码 ]:
3505100000

麦芽糖糊精海关

[ 海关编码 ]: 3505100000

麦芽糖糊精文献

Identification and characterization of MalA in the maltose/maltodextrin operon of Sulfolobus acidocaldarius DSM639.

J. Bacteriol. 195(8) , 1789-99, (2013)

A putative maltose/maltodextrin operon was found in the Sulfolobus acidocaldarius DSM639 genome. The gene cluster consisted of 7 genes (malA, trmB, amyA, malG, malF, malE, and malK). Here, we report t...

Vesicular powder as carrier for doxycycline hydrochloride and metronidazole combination therapy.

Pharm. Dev. Technol. 19(6) , 755-68, (2014)

In this study, vesicular proniosomal powder encapsulating doxycycline hydrochloride (DH) and metronidazole (MT) combination therapy was developed using different types of spans, cholesterol (CH) and m...

Supramolecular complexes of maltodextrin and furosemide polymorphs: a new approach for delivery systems.

Carbohydr. Polym. 94(1) , 292-300, (2013)

We present new supramolecular complexes of two different solid forms of furosemide (I or II) with maltodextrin, in order to explore their application as delivery systems improving the bioavailability ...

更多文献